These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21876046)

  • 1. Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009.
    Hammond SP; Baden LR; Marty FM
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5018-21. PubMed ID: 21876046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis.
    Kyvernitakis A; Torres HA; Jiang Y; Chamilos G; Lewis RE; Kontoyiannis DP
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e1-811.e8. PubMed ID: 27085727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates.
    Guinea J; Escribano P; Vena A; Muñoz P; Martínez-Jiménez MDC; Padilla B; Bouza E
    PLoS One; 2017; 12(6):e0179136. PubMed ID: 28591186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview and outcome of mucormycosis among children with cancer: Report from the Children's Cancer Hospital Egypt.
    Madney Y; Khedr R; Ahmed N; El-Mahallawy H; Youssef A; Taha H; Hassanain O; Ahmed G; Hafez H
    Mycoses; 2019 Nov; 62(11):984-989. PubMed ID: 30983046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in patients With Hematologic Diseases.
    Wang J; Liu L; Li J; Feng X; Yi H; Jiang E; Zheng Y; Zhang F; Zhu X; Mi Y; Han M; Wang J; Feng S
    Mycopathologia; 2024 Aug; 189(4):71. PubMed ID: 39088077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
    Bethge WA; Schmalzing M; Stuhler G; Schumacher U; Kröber SM; Horger M; Einsele H; Kanz L; Hebart H
    Haematologica; 2005 Nov; 90 Suppl():ECR22. PubMed ID: 16266913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.
    Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E;
    BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucormycosis in hematologic patients.
    Pagano L; Offidani M; Fianchi L; Nosari A; Candoni A; Picardi M; Corvatta L; D'Antonio D; Girmenia C; Martino P; Del Favero A;
    Haematologica; 2004 Feb; 89(2):207-14. PubMed ID: 15003897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal Mucormycosis: Our experience with 24 cases.
    Bakshi SS; Das S; Ramesh S; Gopalakrishnan S
    Otolaryngol Pol; 2020 Feb; 74(4):37-40. PubMed ID: 32636347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia and pulmonary mucormycosis.
    Schneidawind D; Nann D; Vogel W; Faul C; Fend F; Horger M; Kanz L; Bethge W
    Transpl Infect Dis; 2012 Dec; 14(6):E166-72. PubMed ID: 23075207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies.
    Abidi MZ; Sohail MR; Cummins N; Wilhelm M; Wengenack N; Brumble L; Shah H; Jane Hata D; McCullough A; Wendel A; Vikram HR; Kusne S; Litzow M; Letendre L; Lahr BD; Poeschla E; Walker RC
    Mycoses; 2014 Nov; 57(11):687-98. PubMed ID: 25040241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Mucormycosis: A 10-Year Systematic Review of Reported Cases and Review of the Literature.
    Otto WR; Pahud BA; Yin DE
    J Pediatric Infect Dis Soc; 2019 Sep; 8(4):342-350. PubMed ID: 31181136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
    Lanternier F; Dannaoui E; Morizot G; Elie C; Garcia-Hermoso D; Huerre M; Bitar D; Dromer F; Lortholary O;
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S35-43. PubMed ID: 22247443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.
    Yano S; Minami J; Nishiwaki K; Shimada T; Dobashi N; Yahagi Y; Takei Y; Takahara S; Ogasawara Y; Sugiyama K; Yamaguchi Y; Saito T; Kasama K; Yokoyama H; Machishima T; Katsube A; Usui N; Aiba K
    Int J Hematol; 2011 Mar; 93(3):344-350. PubMed ID: 21365229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous mucormycosis.
    Vulsteke JB; Deeren D
    Transpl Infect Dis; 2019 Apr; 21(2):e13039. PubMed ID: 30548761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell Transplantation.
    Sakamoto H; Itonaga H; Sawayama Y; Taguchi J; Saijo T; Kuwatsuka S; Hashisako M; Kinoshita N; Oishi M; Doi H; Kosai K; Nishimoto K; Tanaka K; Yanagihara K; Mukae H; Izumikawa K; Miyazaki Y
    Intern Med; 2018; 57(17):2567-2571. PubMed ID: 30175728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.
    Spellberg B; Ibrahim AS; Chin-Hong PV; Kontoyiannis DP; Morris MI; Perfect JR; Fredricks D; Brass EP
    J Antimicrob Chemother; 2012 Mar; 67(3):715-22. PubMed ID: 21937481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases.
    Bonifaz A; Tirado-Sánchez A; Hernández-Medel ML; Araiza J; Kassack JJ; Del Angel-Arenas T; Moisés-Hernández JF; Paredes-Farrera F; Gómez-Apo E; Treviño-Rangel RJ; González GM
    Mycoses; 2021 Apr; 64(4):372-380. PubMed ID: 33253454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive Mucormycosis in Children With Malignancies: Report From the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology.
    Antoniadi K; Iosifidis E; Vasileiou E; Tsipou C; Lialias I; Papakonstantinou E; Kattamis A; Polychronopoulou S; Roilides E; Tragiannidis A
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):176-179. PubMed ID: 32890077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
    Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.